Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - NuGene International, Inc. | s105878_8ka.htm |
Exhibit 16.1
Date: April 9, 2017
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read the statements made by NuGene International, Inc., which we understand will be filed with the Commission, pursuant to Item 4.01 of Form 8-K, as part of the Company's Form 8-K report dated November 18, 2016. We agree with the statements concerning our Firm in such Form 8-K.
| /s/ Dov Weinstein & Co. C.P.A (lsr) | |
| Jerusalem, Israel |
